D. Bennett

Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures.

R. Fisher, S. Schachter, K. Laxer, 1999, Neurology.

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

R. F. Johnston, Robert W. Taylor, Steven C. Johnson, 1994 .

Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.

S. Goldhaber, J. Heit, M. Feldstein, 1992, Journal of the American College of Cardiology.

Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study.

L. Kappos, H. Hartung, E. Radue, 2005 .

Neutralizing antibodies and efficacy of interferon β-1a

L. Kappos, H. Hartung, E. Radue, 2005, Neurology.

Oxcarbazepine adjunctive therapy in infants and young children with partial seizures

D. Bennett, D. Nordli, J. E. Pina-garza, 2005, Neurology.